Entyvio 300 MG vials
Ended Awarded
- Contract number
- SPE2DB25FZS53
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $98,899
Award facts
- Contract value 100% obligated
- $98,898.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $98,898.60 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Entyvio 300 mg vials. This firm fixed-price delivery order, issued on August 11, 2025, is scheduled for completion by September 2, 2025, and represents a continuation of DMS Pharmaceutical Group's ongoing role as a key supplier within the federal pharmaceutical supply chain. The award carries no set-aside designation, indicating the company competed on an unrestricted basis despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499.9 million and valid through November 2026. The underlying IDC, established under the SPE2DB program, enables DLA to procure a comprehensive range of pharmaceutical products—including prescription medications, biologics, and medical consumables—to support military health facilities worldwide. Entyvio, a biologic therapeutic agent used in treating inflammatory bowel disease, falls within the specialized pharmaceutical product categories that DMS Pharmaceutical Group regularly supplies to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FZS53?
SPE2DB25FZS53 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 11, 2025.
How much is contract SPE2DB25FZS53 worth?
The government has obligated $98,899 on SPE2DB25FZS53.
Is contract SPE2DB25FZS53 an order under another contract?
Yes. SPE2DB25FZS53 is a delivery order under SPE2DB22D9244, an indefinite delivery contract.
Was contract SPE2DB25FZS53 competed?
The extent of competition for SPE2DB25FZS53 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award